Search Results - "Addeo R"

Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.

Authors: Addeo R Sperlongano P Montella L et al.

Source: Cancer Chemotherapy & Pharmacology. Oct2012, Vol. 70 Issue 4, p603-609. 7p.

Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide.

Authors: MONTELLA, L. ADDEO, R. GUARRASI, R. et al.

Source: European Journal of Cancer Care. Mar2010, Vol. 19 Issue 2, p200-204. 5p. 1 Chart.

Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women >/=65 years of age.

Authors: Addeo R Faiola V Guarrasi R et al.

Source: Cancer Chemotherapy & Pharmacology. Jul2008, Vol. 62 Issue 2, p285-292. 8p.

URL: 31998872

Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.

Authors: Addeo R Nocera V Faiola V et al.

Source: Supportive Care in Cancer. Feb2008, Vol. 16 Issue 2, p209-214. 6p.

785 SORAFENIB PLUS OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA: UPDATED RESULTS OF A MULTICENTER STUDY

Authors: Del Prete, S. Addeo, R. Caraglia, M. et al.

Source: Journal of Hepatology. Apr2009 Supplement 1, Vol. 50, pS287-S287. 1p.

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Authors: Santini, D. Vincenzi, B. Addeo, R. et al.

Source: Annals of Oncology. Sep2012, Vol. 23 Issue 9, p2313-2318. 6p. 1 Diagram, 3 Charts, 1 Graph.

Two Case Reports of Biliary Tract Injuries during Laparoscopic Cholecystectomy.

Authors: Romano, O. Romano, C. Cerbone, D. et al.

Source: ISRN Gastroenterology. 2011, Special section p1-4. 4p.

Epigenetic control of gene expression: Potential implications for cancer treatment.

Authors: Perri, F. Longo, F. Giuliano, M. et al.

Source: Critical Reviews in Oncology/Hematology. Mar2017, Vol. 111, p166-172. 7p.

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients.

Authors: Vincenzi, B. Galluzzo, S. Santini, D. et al.

Source: Annals of Oncology. May2011, Vol. 22 Issue 5, p1141-1146. 6p. 4 Charts, 2 Graphs.

826 SKIN TOXICITY AS A PREDICTIVE FACTOR FOR TUMOR CONTROL IN ADVANCED HCC PATIENTS TREATED WITH SORAFENIB

Authors: Vincenzi, B. Santini, D. Frezza, A. et al.

Source: Journal of Hepatology. Apr2009 Supplement 1, Vol. 50, pS302-S302. 1p.

Enhancing audiometric surveillance in head and neck cancer patients undergoing cisplatin-based chemoradiation.

Authors: Mirabile A Addeo R

Source: Chinese clinical oncology [Chin Clin Oncol] 2025 Dec; Vol. 14 (6), pp. 65.

Publication Type: Editorial

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101608375 Publication Model: Print Cited Medium: Internet ISSN: 2304-3873 (Electronic) Linking ISSN: 23043865 NLM ISO Abbreviation: Chin Clin Oncol Subsets: MEDLINE; In Process

Investigational new drugs to treat brain metastasis from non-small cell lung cancer.

Authors: Vitale P Lamberti G di Giovanni I et al.

Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Jul-Aug; Vol. 34 (7-8), pp. 557-570. Date of Electronic Publication: 2025 Jul 11.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

Authors: Caterino M Lo Giudice G Damiano V et al.

Source: Frontiers in oncology [Front Oncol] 2025 May 06; Vol. 15, pp. 1557652. Date of Electronic Publication: 2025 May 06 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Current status and perspective of immunotherapy for head and neck squamous cell carcinoma.

Authors: Vitale P Di Giovanni I Tammaro C et al.

Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2026 Jan-Feb; Vol. 35 (2), pp. 151-168. Date of Electronic Publication: 2026 Feb 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Cancer.

Authors: Fasano M Perri F Pirozzi M et al.

Source: Cancers [Cancers (Basel)] 2025 Nov 02; Vol. 17 (21). Date of Electronic Publication: 2025 Nov 02.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Early phase development of PI3kinase inhibitors for anticancer therapies.

Authors: Caputo C Lombardi A Vicario M et al.

Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2025 Nov; Vol. 34 (11), pp. 905-920. Date of Electronic Publication: 2025 Nov 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?

Authors: Vitale P De Falco V Addeo R

Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Jul; Vol. 24 (7), pp. 481-484. Date of Electronic Publication: 2024 May 13.

Publication Type: Editorial

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

Zinc Supplementation in Head and Neck Cancer: Prevention of Chemo-Radio-Induced Complications and an Opportunity for Treatment.

Authors: Addeo R Caraglia F Fasano M et al.

Source: Oncology [Oncology] 2024; Vol. 102 (11), pp. 1004-1008. Date of Electronic Publication: 2024 Jul 17.

Publication Type: Letter

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE; In Process

The First Case Report of a Solitary Pulmonary Metastasis of a Transitional Meningioma and Literature Review.

Authors: Di Lorenzo S Farese S Balbo C et al.

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 17; Vol. 26 (14). Date of Electronic Publication: 2025 Jul 17.

Publication Type: Journal Article; Case Reports; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

New Anticancer Agents: Design, Synthesis and Evaluation.

Authors: Pokrovsky V Addeo R Coluccia M

Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jun 25; Vol. 26 (13). Date of Electronic Publication: 2025 Jun 25.

Publication Type: Editorial; Introductory Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE